Insoluble protein plaques in the Alzheimer's 
.
Alzheimer's Donation
Donate Online Now
.
Alzheimer's disease (AD) affects as much as 10% of the world population above 65 years of age but after years of research it is still not understood exactly how the disease appears and, even less, how to treat it. But work just published in The EMBO Journal opens the door to new ways for disease intervention by showing that lipids found throughout the brain can dissolve the large insoluble protein plaques characteristic of the disease, releasing their soluble protofibrillar components, and also that it is the soluble components and not the insoluble plaques that provoke neural death. These results identify a new target for disease intervention - the soluble protofibrillar components - but also alert for the fact that the insoluble plaques are, nevertheless, reservoirs of toxicity and so will need to be controlled too, while also identifying a totally new influence in the disease - the patients' lipid metabolism - and in this way add a few important pieces to the puzzle that is AD.
Alzheimer's is a progressive fatal illness that results from the death of certain brain areas associated with cognitive functions such as memory and learning. Starting with forgetfulness as the disease progresses patients suffer major personality changes and, eventually, a terrifying loss of the "self" occurs. The disease is associated with an abnormal amyloid-beta (Aβ) protein that incapable of fold properly -all proteins need specific 3D structures to work properly - accumulates instead in large insoluble deposits (or amyloids) in the brain of patients exactly where neurons' death occurr. These insoluble plaques have a fibrillar structure and originate from the agglomeration of free Aβ-peptide after an intermediate state as soluble protofibrills.
Although initially it was thought that the large fibrillar plaques were behind the disease, more recent research seems to suggest that it is the intermediate protofibrillar form that is neurotoxic. Also recently there has been increasing suggestions of a link between AD and alterations in the lipid metabolism of patients, while some lipids - such as cholesterol - have been shown to affect the formation of the insoluble plaques.
Trying to understand better what is happening in the disease Ivo Cristiano Martins, Inna Kuperstein, Joost Schymkowitz, Frederic Rousseau and colleagues at the VIB Switch Laboratory, Vrije Universiteit Brussel, and the VIB Department of Molecular and Developmental Genetics,K.U.Leuven, Belgium decided to test the effect of different biological lipids on both the protofibrillar and the fibrillar forms of the aberrant Aβ-protein, while also analysing how all these factors affected the neurodegeneration characteristic of AD.
To start, the team of researchers exposed insoluble fibrillar plaques like those found in patients' brains to several naturally occurring lipids - such as cholesterol - to find that in their presence the plaques partially dissolved, releasing the soluble protofibrills that constitute them. This result showed, for the first time, that the formation of plaques was a reversible process and as such could be manipulated if necessary.
Martins, Kuperstein and colleagues then tested the neurotoxicity of the obtained protofibrills and show that they were able, not only of kill isolated neurons, but also of affect the brain of injected mice. The insoluble fibrills (plaques) were shown to be biologically inert on both cases. To further investigate the different neurotoxicities of the fibrillar versus the protofibrillar form of Aβ-peptide, mice were injected with one or the other and tested for memory and learning capacities (both cognitive capabilities affected in Alzheimer's). Again it was found that only the protofibrillar form deteriorated mice capabilities to perform. Interestingly, the damaging effect was temporary agreeing with the idea that the protofibrills eventually turned into the inert fibrillar plaques in a process similar to what occurs in AD.
Martins, Kuperstein and colleagues' work has several important implications. Their results confirm that it is the protofibrillar form of Aβ-peptide that is neurotoxic and not the insoluble fibrillar plaques but also reveals - by showing that plaque formation is reversible - that the plaques are, nevertheless, reservoirs of toxicity. They also suggest that disturbances in the metabolism of lipids have the potential to influence the development of AD and may be the reason behind the fact that many times the extension of the insoluble plaques in the brain of AD patients does not correlate with their disease severity.
As Ivo Martins - a Portuguese researcher and one of the main authors explains - "before our work the plaques were seen as relatively innocuous, the last stage of the disease, but what we show here is that they are in reality a" time bomb" ready to be activated by interacting with lipids" http://www.medicalnewstoday.com
Digestion to take over from heart health, report claims
The increasing use of probiotics and antioxidants will continue to develop in 2008 but products positioned at heart health will not perform so well, a report has said. http://www.dairyreporter.com
Alzheimer's is a progressive fatal illness that results from the death of certain brain areas associated with cognitive functions such as memory and learning. Starting with forgetfulness as the disease progresses patients suffer major personality changes and, eventually, a terrifying loss of the "self" occurs. The disease is associated with an abnormal amyloid-beta (Aβ) protein that incapable of fold properly -all proteins need specific 3D structures to work properly - accumulates instead in large insoluble deposits (or amyloids) in the brain of patients exactly where neurons' death occurr. These insoluble plaques have a fibrillar structure and originate from the agglomeration of free Aβ-peptide after an intermediate state as soluble protofibrills.
Although initially it was thought that the large fibrillar plaques were behind the disease, more recent research seems to suggest that it is the intermediate protofibrillar form that is neurotoxic. Also recently there has been increasing suggestions of a link between AD and alterations in the lipid metabolism of patients, while some lipids - such as cholesterol - have been shown to affect the formation of the insoluble plaques.
Trying to understand better what is happening in the disease Ivo Cristiano Martins, Inna Kuperstein, Joost Schymkowitz, Frederic Rousseau and colleagues at the VIB Switch Laboratory, Vrije Universiteit Brussel, and the VIB Department of Molecular and Developmental Genetics,K.U.Leuven, Belgium decided to test the effect of different biological lipids on both the protofibrillar and the fibrillar forms of the aberrant Aβ-protein, while also analysing how all these factors affected the neurodegeneration characteristic of AD.
To start, the team of researchers exposed insoluble fibrillar plaques like those found in patients' brains to several naturally occurring lipids - such as cholesterol - to find that in their presence the plaques partially dissolved, releasing the soluble protofibrills that constitute them. This result showed, for the first time, that the formation of plaques was a reversible process and as such could be manipulated if necessary.
Martins, Kuperstein and colleagues then tested the neurotoxicity of the obtained protofibrills and show that they were able, not only of kill isolated neurons, but also of affect the brain of injected mice. The insoluble fibrills (plaques) were shown to be biologically inert on both cases. To further investigate the different neurotoxicities of the fibrillar versus the protofibrillar form of Aβ-peptide, mice were injected with one or the other and tested for memory and learning capacities (both cognitive capabilities affected in Alzheimer's). Again it was found that only the protofibrillar form deteriorated mice capabilities to perform. Interestingly, the damaging effect was temporary agreeing with the idea that the protofibrills eventually turned into the inert fibrillar plaques in a process similar to what occurs in AD.
Martins, Kuperstein and colleagues' work has several important implications. Their results confirm that it is the protofibrillar form of Aβ-peptide that is neurotoxic and not the insoluble fibrillar plaques but also reveals - by showing that plaque formation is reversible - that the plaques are, nevertheless, reservoirs of toxicity. They also suggest that disturbances in the metabolism of lipids have the potential to influence the development of AD and may be the reason behind the fact that many times the extension of the insoluble plaques in the brain of AD patients does not correlate with their disease severity.
As Ivo Martins - a Portuguese researcher and one of the main authors explains - "before our work the plaques were seen as relatively innocuous, the last stage of the disease, but what we show here is that they are in reality a" time bomb" ready to be activated by interacting with lipids" http://www.medicalnewstoday.com
Digestion to take over from heart health, report claims
The increasing use of probiotics and antioxidants will continue to develop in 2008 but products positioned at heart health will not perform so well, a report has said. http://www.dairyreporter.com
Posted YVN
posted by Valery Yermalitsky at
8:23 AM
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home